Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…
In a new study published in JAMA Neurology, researchers reported the first results of an initial basket trial for neurodegenerative diseases. The trial brings…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us